ID
31029
Description
Study ID: 104505 Clinical Study ID: BEX104505 Study Title: Phase II Study of Iodine 131 Anti B1 Antibody for 1st or 2nd Relapsed Indolent B-Cell Lymphomas or B-Cell Lymphomas That Have Transformed to a More Aggressive Histology Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00950755 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 2 Study Recruitment Status: Completed Generic Name: tositumomab Trade Name: Bexxar Study Indication: Lymphoma, Non-Hodgkin Please record all prior radiation therapies for NHL.
Keywords
Versions (1)
- 7/12/18 7/12/18 -
Copyright Holder
see clinicaltrials.gov
Uploaded on
July 12, 2018
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Iodine 131 B1 Antibody for B-Cell Lymphomas NCT00950755
Prior Radiation Therapy
- StudyEvent: ODM
Description
Prior Radiation Therapy
Alias
- UMLS CUI-1
- C1522449
- UMLS CUI-2
- C0332152
Description
Radiation Therapy Start Date
Data type
date
Alias
- UMLS CUI [1,1]
- C1522449
- UMLS CUI [1,2]
- C0808070
Description
Radiation Therapy, End Date
Data type
date
Alias
- UMLS CUI [1,1]
- C1522449
- UMLS CUI [1,2]
- C0806020
Description
radiation therapy pattern total dose
Data type
float
Measurement units
- cGy
Alias
- UMLS CUI [1]
- C2169193
Description
Radiotherapy, irradiation site
Data type
text
Alias
- UMLS CUI [1,1]
- C1522449
- UMLS CUI [1,2]
- C2169202
Description
Radiotherapy, Outcome of Therapy
Data type
text
Alias
- UMLS CUI [1,1]
- C1522449
- UMLS CUI [1,2]
- C1518681
Similar models
Prior Radiation Therapy
- StudyEvent: ODM
C0600091 (UMLS CUI [1,2])
C0332152 (UMLS CUI-2)
C0808070 (UMLS CUI [1,2])
C0806020 (UMLS CUI [1,2])
C2169202 (UMLS CUI [1,2])
C1518681 (UMLS CUI [1,2])